1. Home
  2. DRMA vs SAG Comparison

DRMA vs SAG Comparison

Compare DRMA & SAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • SAG
  • Stock Information
  • Founded
  • DRMA 2014
  • SAG 1975
  • Country
  • DRMA United States
  • SAG Singapore
  • Employees
  • DRMA N/A
  • SAG N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • SAG
  • Sector
  • DRMA Health Care
  • SAG
  • Exchange
  • DRMA Nasdaq
  • SAG NYSE
  • Market Cap
  • DRMA 6.1M
  • SAG 7.1M
  • IPO Year
  • DRMA 2021
  • SAG 2024
  • Fundamental
  • Price
  • DRMA $0.99
  • SAG $0.81
  • Analyst Decision
  • DRMA Strong Buy
  • SAG
  • Analyst Count
  • DRMA 1
  • SAG 0
  • Target Price
  • DRMA $6.00
  • SAG N/A
  • AVG Volume (30 Days)
  • DRMA 4.1M
  • SAG 8.3M
  • Earning Date
  • DRMA 05-14-2025
  • SAG 12-19-2024
  • Dividend Yield
  • DRMA N/A
  • SAG N/A
  • EPS Growth
  • DRMA N/A
  • SAG N/A
  • EPS
  • DRMA N/A
  • SAG 0.21
  • Revenue
  • DRMA N/A
  • SAG $56,387,000.00
  • Revenue This Year
  • DRMA N/A
  • SAG N/A
  • Revenue Next Year
  • DRMA N/A
  • SAG N/A
  • P/E Ratio
  • DRMA N/A
  • SAG $3.93
  • Revenue Growth
  • DRMA N/A
  • SAG N/A
  • 52 Week Low
  • DRMA $0.95
  • SAG $0.47
  • 52 Week High
  • DRMA $6.66
  • SAG $8.27
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 35.86
  • SAG N/A
  • Support Level
  • DRMA $1.16
  • SAG N/A
  • Resistance Level
  • DRMA $2.37
  • SAG N/A
  • Average True Range (ATR)
  • DRMA 0.17
  • SAG 0.00
  • MACD
  • DRMA -0.03
  • SAG 0.00
  • Stochastic Oscillator
  • DRMA 2.86
  • SAG 0.00

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About SAG SAG HOLDINGS LTD

SAG Holdings Ltd engages in the business of distributing automotive and industrial spare parts with operations primarily based in Singapore, and global sales primarily generated from the Middle East and Malaysia. Its business is comprised of On-Highway Business serving the automotive sector and Off-Highway Business primarily servicing the marine, energy, mining, construction, agriculture, and oil and gas sectors. The On-Highway Business Segment supply genuine and aftermarket spare parts to customers through our Autozone retail outlets located in Singapore, as well as Malaysia. The Off-Highway Business Segment supply a wide range of components and spare parts for internal combustion engines with a strong focus on filtration products through Filtec.

Share on Social Networks: